CSBR - Company ID 0000771856
CHAMPIONS ONCOLOGY, INC. (CSBR) reported net income of -$1.18K for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2026 | -$1.18K | -100.0% |
| FY 2025 | $4.70M | +164.6% |
| FY 2024 | -$7.28M | -36.4% |
| FY 2023 | -$5.33M | -1073.5% |
| FY 2022 | $548.00K | +51.4% |
| FY 2021 | $362.00K | +117.3% |
| FY 2020 | -$2.09M | -1735.2% |
| FY 2019 | $128.00K | +108.7% |
| FY 2018 |
CHAMPIONS ONCOLOGY, INC. (CSBR) reported net income of -$1.18K for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2026, CHAMPIONS ONCOLOGY, INC.'s net income grew from -$8.66M to -$1.18K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$1.48M |
| +78.6% |
| FY 2017 | -$6.88M | +34.1% |
| FY 2016 | -$10.45M | +20.5% |
| FY 2015 | -$13.14M | -77.4% |
| FY 2014 | -$7.41M | -17.0% |
| FY 2013 | -$6.33M | +26.9% |
| FY 2012 | -$8.66M | - |